(Q80733052)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17674353%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

title

Neoadjuvant docetaxel treatment for locally advanced prostate cancer: a clinicopathologic study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17674353%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1 reference

1 reference

Cristina Magi-Galluzzi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17674353%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Ming Zhou

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17674353%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Alwyn M Reuther

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17674353%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Robert Dreicer

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17674353%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Eric A Klein

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17674353%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

publication date

1 September 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17674353%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

number of pages

7

1 reference

inferred from page(s)

published in

Cancer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17674353%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

volume

110

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17674353%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17674353%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

page(s)

1248-1254

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17674353%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

cites work

Cancer statistics, 2006

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22897

7 January 2021

Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22897

7 January 2021

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22897

7 January 2021

Signal transduction pathways of taxanes-induced apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22897

7 January 2021

Phase II trial of neoadjuvant docetaxel before radical prostatectomy for locally advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22897

7 January 2021

Current indications for chemotherapy in prostate cancer patients.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22897

7 January 2021

A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22897

7 January 2021

Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22897

7 January 2021

Long-term followup of a randomized trial of 0 versus 3 months of neoadjuvant androgen ablation before radical prostatectomy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22897

7 January 2021

Phase II trial of neoadjuvant estramustine and etoposide plus radical prostatectomy for locally advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22897

7 January 2021

Neoadjuvant docetaxel before radical prostatectomy in patients with high-risk localized prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22897

7 January 2021

Neoadjuvant docetaxel and estramustine chemotherapy in high-risk/locally advanced prostate cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22897

7 January 2021

Paclitaxel, estramustine phosphate, and carboplatin in patients with advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22897

7 January 2021

An interdisciplinary approach to treating prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22897

7 January 2021

Neoadjuvant docetaxel followed by radical prostatectomy in patients with high-risk localized prostate cancer: a preliminary report

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22897

7 January 2021

Neoadjuvant chemotherapy and hormonal therapy followed by radical prostatectomy: feasibility and preliminary results

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22897

7 January 2021

Identifiers

DOI

10.1002/CNCR.22897

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17674353%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1 reference